Guifang Guo

State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study.

Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study.

Journal: Molecular cancer

Published: May 29, 2025

Efficacy and Safety of Different Sequences for mFOLFIRINOX (or SOXIRI) and Gemcitabine Plus Albumin-Bound Paclitaxel in Unresectable Pancreatic Cancer.

Efficacy and Safety of Different Sequences for mFOLFIRINOX (or SOXIRI) and Gemcitabine Plus Albumin-Bound Paclitaxel in Unresectable Pancreatic Cancer.

Journal: ImmunoTargets and therapy

Published: April 24, 2025

Comprehensive analysis of the functional and immunological significance of ETV4 in pan-cancer and its validation in digestive tumors.

Comprehensive analysis of the functional and immunological significance of ETV4 in pan-cancer and its validation in digestive tumors.

Journal: Frontiers in immunology

Published: March 18, 2025

EBV enhances immunotherapy sensitivity in intrahepatic cholangiocarcinoma through cGAS-STING pathway activation.

EBV enhances immunotherapy sensitivity in intrahepatic cholangiocarcinoma through cGAS-STING pathway activation.

Journal: Hepatology communications

Published: December 07, 2024

Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.

Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.

Journal: Cancer immunology, immunotherapy : CII

Published: April 07, 2024

Anatomical classification of advanced biliary tract cancer predicts programmed cell death protein 1 blockade efficacy.

Anatomical classification of advanced biliary tract cancer predicts programmed cell death protein 1 blockade efficacy.

Journal: Frontiers in pharmacology

Published: January 29, 2024

Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer.

Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer.

Journal: Therapeutic advances in medical oncology

Published: December 16, 2022

Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.

Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.

Journal: Cancer medicine

Published: November 30, 2022

Soil conditions and the plant microbiome boost the accumulation of monoterpenes in the fruit of Citrus reticulata 'Chachi'.

Soil conditions and the plant microbiome boost the accumulation of monoterpenes in the fruit of Citrus reticulata 'Chachi'.

Journal: Microbiome

Published: October 30, 2022

Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metastasis and a Nomogram Prediction Model for Survival.

Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metastasis and a Nomogram Prediction Model for Survival.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: October 13, 2022

Efficacy of the Nourishing Yin and Clearing Heat Therapy Based on Traditional Chinese Medicine in the Prevention and Treatment of Radiotherapy-Induced Oral Mucositis in Nasopharyngeal Carcinomas: A Systematic Review and Meta-Analysis of Thirty Randomized Controlled Trials.

Efficacy of the Nourishing Yin and Clearing Heat Therapy Based on Traditional Chinese Medicine in the Prevention and Treatment of Radiotherapy-Induced Oral Mucositis in Nasopharyngeal Carcinomas: A Systematic Review and Meta-Analysis of Thirty Randomized Controlled Trials.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: November 18, 2021

Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis.

Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis.

Journal: Frontiers in immunology

Published: October 26, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026